Ivar P. Gladhaug

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Manoj Amrutkar · 14 shared papers, 2017–2026 · strength 3.00
   • Paper Proteomic characterization of primary pancreatic fibroblasts derived from neoadjuvant chemotherapy treated versus treat… DOI 10.1016/j.jprot.2026.105660↗
   • Paper Reduced lipid metabolite abundance in human pancreatic cancer and matched serum samples following neoadjuvant FOLFIRINO… DOI 10.1007/s11306-025-02388-z↗
   • Paper Proteomic Characterization of Primary Human Pancreatic Cancer Cell Lines Following Long-Term Exposure to Gemcitabine. DOI 10.3390/proteomes13040048↗
2. Caroline Sophie Verbeke · 13 shared papers, 2016–2026 · strength 2.64
   • Paper Proteomic characterization of primary pancreatic fibroblasts derived from neoadjuvant chemotherapy treated versus treat… DOI 10.1016/j.jprot.2026.105660↗
   • Paper Reduced lipid metabolite abundance in human pancreatic cancer and matched serum samples following neoadjuvant FOLFIRINO… DOI 10.1007/s11306-025-02388-z↗
   • Paper Proteomic Characterization of Primary Human Pancreatic Cancer Cell Lines Following Long-Term Exposure to Gemcitabine. DOI 10.3390/proteomes13040048↗
3. Knut Jørgen Labori · 5 shared papers, 2016–2026 · strength 1.25
   • Paper Proteomic characterization of primary pancreatic fibroblasts derived from neoadjuvant chemotherapy treated versus treat… DOI 10.1016/j.jprot.2026.105660↗
   • Paper Reduced lipid metabolite abundance in human pancreatic cancer and matched serum samples following neoadjuvant FOLFIRINO… DOI 10.1007/s11306-025-02388-z↗
   • Paper Global metabolomic profiling of tumor tissue and paired serum samples to identify biomarkers for response to neoadjuvan… DOI 10.1002/1878-0261.13759↗
4. Petra Sántha · 3 shared papers, 2019–2021 · strength 0.37
   • Paper Morphological Heterogeneity in Pancreatic Cancer Reflects Structural and Functional Divergence. DOI 10.3390/cancers13040895↗
   • Paper Differential Gemcitabine Sensitivity in Primary Human Pancreatic Cancer Cells and Paired Stellate Cells Is Driven by He… DOI 10.3390/cancers12123628↗
   • Paper Commonly Used Pancreatic Stellate Cell Cultures Differ Phenotypically and in Their Interactions with Pancreatic Cancer … DOI 10.3390/cells8010023↗
5. Daniela M. Lenggenhager · 2 shared papers, 2019–2021 · strength 0.25
   • Paper Morphological Heterogeneity in Pancreatic Cancer Reflects Structural and Functional Divergence. DOI 10.3390/cancers13040895↗
   • Paper Commonly Used Pancreatic Stellate Cell Cultures Differ Phenotypically and in Their Interactions with Pancreatic Cancer … DOI 10.3390/cells8010023↗
6. Yuchuan Li · 1 shared paper, 2023 · strength 0.22
   • Paper Fatty acids abrogate the growth-suppressive effects induced by inhibition of cholesterol flux in pancreatic cancer cell… DOI 10.1186/s12935-023-03138-8↗
7. Vegard Tjomsland · 2 shared papers, 2016–2017 · strength 0.17
   • Paper Functional heterogeneity in tumor-derived human pancreatic stellate cells: Differential expression of HGF and implicati… DOI 10.18632/oncotarget.17800↗
   • Paper Profile of MMP and TIMP Expression in Human Pancreatic Stellate Cells: Regulation by IL-1α and TGFβ and Implications fo… DOI 10.1016/j.neo.2016.06.003↗
8. Matthias J. Löhr · 1 shared paper, 2019 · strength 0.11
   • Paper Commonly Used Pancreatic Stellate Cell Cultures Differ Phenotypically and in Their Interactions with Pancreatic Cancer … DOI 10.3390/cells8010023↗
9. Trond A Buanes · 2 shared papers, 2011–2016 · strength 0.08
   • Paper Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival i… DOI 10.3109/0284186x.2015.1068445↗
   • Paper Long-term follow-up of patients with resected pancreatic cancer following vaccination against mutant K-ras. DOI 10.1002/ijc.25449↗
10. Matthew H. G. Katz · 1 shared paper, 2016 · strength 0.05
    • Paper Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival i… DOI 10.3109/0284186x.2015.1068445↗
11. Bjørn Edwin · 1 shared paper, 2016 · strength 0.05
    • Paper Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival i… DOI 10.3109/0284186x.2015.1068445↗
12. Svein Dueland · 1 shared paper, 2016 · strength 0.05
    • Paper Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival i… DOI 10.3109/0284186x.2015.1068445↗
13. Elin Hegland Kure · 1 shared paper, 2016 · strength 0.05
    • Paper Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival i… DOI 10.3109/0284186x.2015.1068445↗
14. Synne Wedén · 1 shared paper, 2011 · strength 0.03
    • Paper Long-term follow-up of patients with resected pancreatic cancer following vaccination against mutant K-ras. DOI 10.1002/ijc.25449↗
15. Gustav Gaudernack · 1 shared paper, 2011 · strength 0.03
    • Paper Long-term follow-up of patients with resected pancreatic cancer following vaccination against mutant K-ras. DOI 10.1002/ijc.25449↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.